Telephone consultations for tissue plasminogen activator administration in acute stroke.
Effective treatment for acute ischemic stroke has been available for 17 years, but wide geographic variability remains in timely access to neurologic expertise and other components of stroke systems of care. Telemedical technology can be used to improve such access, but it is debatable whether neurologists have an ethical obligation to provide consultation regarding tissue plasminogen activator use via the telephone. This article examines whether neurologists are ethically obligated to provide telephone-mediated acute stroke consultation.
Justin A
JA
Sattin
D002545:Brain Ischemia / Q000188:drug therapy*; D006801:Humans; D019114:Remote Consultation / Q000941:ethics*; D020521:Stroke / Q000188:drug therapy*; D013689:Telephone; D015912:Thrombolytic Therapy / Q000941:ethics*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D010959:Tissue Plasminogen Activator